分享到朋友圈
8
5
243
0
2020中国临床肿瘤学年度进展
2022 CSCO CAR-T指南原则
Efficacy and safety of CAR-T cell therapy by relma-cel vs. liso-cel in treating relapse/refractory large B cell lymphoma
吉西他滨,奥沙利铂联合利妥昔单抗一线治疗老年弥漫大B细胞淋巴瘤:一项单臂,开放,2期研究
血液肿瘤ADC药物临床进展